Study of Medicine Dosage Adjustments in Inpatients with Chronic Kidney Disease

https://doi.org/10.22146/jmpf.88181

Katharina Kening Weking(1*), Liniati Geografi(2), Clara Ritawany Sinaga(3)

(1) Program Studi S1 Farmasi, Sekolah Tinggi Ilmu Kesehatan Dirgahayu Samarinda
(2) Program Studi S1 Farmasi, Sekolah Tinggi Ilmu Kesehatan Dirgahayu Samarinda
(3) Program Studi S1 Farmasi, Sekolah Tinggi Ilmu Kesehatan Dirgahayu Samarinda
(*) Corresponding Author

Abstract


Background: Decreased kidney function in patients with Chronic Kidney Disease (CKD) necessitates dose adjustment, especially for medicines that have a narrow therapeutic index to avoid unwanted medicine effects.

Objectives: The purpose of this study was to determine the medicine dosage adjustments in CKD patients and their therapy outcomes.

Methods: This type of research is descriptive with a retrospective approach. The sample in this study is the medical records of inpatient CKD patients at Abdoel Wahab Sjahranie Samarinda Hospital for the period May to November 2022. Calculation of GFR (Glomerular Filtration Rate) uses the MDRD (Modification of Diet in Renal Disease) formula.

Results: The results showed that the sex of most patients was male as many as 56.25%. The age of most patients in the range of 53-59 years old as many as 33.75%. Most CKD severity level is stage 5 as many as 91.25%. The most common comorbidities were hypertension (61 patients), diabetes mellitus (15 patients), and edema or pulmonary edema (11 patients). There were 77 patients requiring dose adjustment out of a total of 80 patients. There were 149 (34.89%) medicines requiring dose adjustment out of a total of 427 medicines, with the 5 most medicines being calcium carbonate (24.16%), furosemide (24.16%), metoclopramide (10.74%), paracetamol (10.74%), and ranitidine (7.39%). There were 128 (85.91%) medicines with doses appropriate to the Lexicomp 2023 or Renal Pharmacotherapy 2013. The therapy outcome improved in patients who required dose adjustments by 90.91%.

Conclusion: It is recommended to calculate GFR using a new formula such as eGFR using CKD-EPI, and collecting data with a larger number of samples.


Keywords


Chronic kidney disease; Dose adjustment; Glomerular filtration rate; Hospital

Full Text:

PDF


References

  1. Efendi, Z., Irwan, M., Zalni, R. I., Roni, Y. 2021. Faktor-Faktor Yang Berhubungan Dengan Kualitas Hidup Pasien Dengan Gagal Ginjal Kronik Yang Menjalani Hemodialisa. Jurnal Kesehatan Maharatu: 2(2):12-26.
  2. Kementerian Kesehatan Republik Indonesia. 2013. Hasil Utama Riskesdas 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia.
  3. Kementerian Kesehatan RI. 2018. Laporan Provinsi Kalimantan Timur Riskesdas 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia.
  4. DiPiro, Joseph T., Yee, Gary C., Posey, L Michael., Haines, Stuart T., Nolin, Thomas D., Ellingrod, Vicki. 2020. Pharmacotherapy A Pathophysiologic Approach Eleventh Edition. McGraw-Hill Education eBook.
  5. Kidney Disease Improving Global Outcomes. 2021. Clinical Practice Guideline for the Management of Glomerular Diseases. Official Journal Of The International Society Of Nephrology: 100(45):S1-S276.
  6. Gunawan. 2012. Farmakologi Dan Terapi Edisi 5. Jakarta : Departemen Farmakologi dan Terapeutik Fakultas Kedokteran Universitas Indonesia.
  7. Andriani, S., Rahmawati, F., Andayani, T. M. 2021. Penyesuaian Dosis Obat pda Pasien Gagal Ginjal Kronis Rawat Inap di Rumah Sakit Kabupaten Tegal, Indonesia. Majalah Farmaseutik: 17(1):46-53.
  8. Veryanti, P. R., Meiliana, M. L. 2018. Evaluasi Kesesuaian Dosis Obat Pada Pasien gagal Ginjal Kronik. Saintech Farma: 11(1):12-17.
  9. Setyawan, Yuswanto. 2021. Merokok dan Gangguan Fungsi Ginjal. e-CliniC: 9(2):388-396.
  10. Pongsibidang, G.S. 2017. Risiko Hipertensi, Diabetes, dan Konsumsi Minuman Herbal Pada Kejadian Gagal Ginjal Kronik Di RSUP Dr. Wahidin Sudirohusodo Makassar. Jurnal Wiyata Penelitian Sains dan Kesehatan: 3(2):162-167.
  11. Puspitasari, P., Kusnadi, D. 2015. Hubungan Antara Konsumsi Minuman Berenergi Yang Mengandung Kombinasi Taurin Dan Kafein Dengan Angka Kejadian Gagal Ginjal Kronis. Jurnal Kesehatan Hesti Wira Sakti: 3(3):54-61.
  12. Tjekyan, Suryadi. 2014. Prevalensi dan Faktor Risiko Penyakit Ginjal Kronik di RSUP Dr. Mohammad Hoesin Palembang Tahun 2012. Palembang: Fakultas Kedokteran Universitas Sriwijaya.
  13. Septi, D., Apen, Afgani., AL, Garina. 2014. Karakteristik Penderita Gagal Ginjal Kronis yang Dilakukan Hemodialisis di RSUD Al-Ihsan Tahun 2014. Bandung: Universitas Islam Bandung.
  14. Gajjala, PR., Sanati, M., Jankowski, J. 2015. Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Melitus and Cardiovascular Disease as its Comorbidities. Front Immunol: 6:1-15.
  15. Afiatin., Roesli, Rully M A. 2017. Laju Filtrasi Glomerulus Dengan Metoda eGFR. Universitas Padjadjaran: Pustaka Ilmiah.
  16. Alldredge B.K., Corelli R.L., Ernest M.E., Guglielmo B.J., Jacobson P.A., Kradjan W.A., Williams B.R. 2013. Koda-Kimble &Young’s Applied Therapeutics the clinical use of medicines. 10th edition. Philadelphia: Liippincott Williams & Wilkins.
  17. Pradesya, Ezra Senna., Faesol, H. Ahmad. 2016. Hubungan Gagal Ginjal Kronik Dengan Edema Paru Ditinjau Dari Gambaran Radiologi. Universitas Muhammadiyah Yogyakarta: Research Repository.
  18. Sholihah, Inayatush., Santoso, Joko., Rahardjoputro, Rolando. 2022. Gambaran Penggunaan Pengikat Fosfat pada Pasien Penyakit Ginjal Kronik dengan Hemodialisis. INPHARNMED Journal (Indonesian Pharmacy and Natural Medicine Journal): 6(2):91-97.
  19. Sorensen, M.D. Calcium Intake and Urinary Stone Disease. Translational Andrology and Urology: 3(3):235-240.
  20. Bruyne, L.K.M De. 2003. Mechanisms and Management of Diuretic Resistance in Congestive Heart Failure. Postgrad Med J: 79(931):268-71.
  21. Wilcox, C.S. 1996. Diuretics. In: Brenner BM, Rector FC, editors. The Kidney. Philadelphia: WB Saunders. 2299-330.
  22. Joshi, Shivam., Chaknos, Michael. 2019. Diuretic Dosing in Heart Failure and Chronic Kidney Disease. Journal of Clinical Nephrology & Kidney Diseases Case Report: 4(1): 1019.
  23. European Medicines Agency. 2014. Metoclopramide Art. 31 - Annex III -en. European Medicines Agency: Science Medicines Health.
  24. Bertram G, Katzung. 2010. Farmakologi Dasar dan Klinik 10th edition. Jakarta: EGC.
  25. Kanchanasurakit, Sukrit., Arsu, Aimusa., Siriplabpla, Wuttikorn., Duangjai, Acharaporn., Saokaew, Surasak. 2020. Acetaminophen Use and Risk of Renal Impairment: A Systematic Review and Meta-Analysis. National Library of Medicine, National Center for Biotechnology Information, Kidney Research and Clinical Practice: 39(1):81-92.
  26. Hammer, G.D., McPhee, S.J. 2019. Pathophysiology of Disease: An Introduction to Clinical Medicine. Seventh Edition. New York: McGraw-Hill Education.
  27. Lucida, Henny., Trisnawati., Riah., Suardi, Muslim. 2011. Anlisis Aspek Farmakokinetika Klinik Pasien Gagal Ginjal pada Irna Penyakit Dalam RSUP Dr. M. Djamil Padang. Padang: Repositori Universitas Andalas.



DOI: https://doi.org/10.22146/jmpf.88181

Article Metrics

Abstract views : 997 | views : 426

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats